Dermatrials Research

Dermatrials Research is a Canadian independent research site specializing in dermatology clinical trials with a focus on psoriasis and related inflammatory skin diseases. The center has participated as a site for over 100 clinical studies, including pivotal global phase II–IV programs evaluating novel small molecules and biologics for moderate-to-severe plaque psoriasis and psoriatic arthritis. The principal investigator is Dr. Ron Vender, an experienced dermatologist with over two decades of research experience. Recent studies at the site include those investigating TAK-279, risankizumab, JNJ‑77242113, LY4100511, ESK‑001, guselkumab—primarily targeting moderate-to-severe plaque psoriasis or psoriatic arthritis.